- Home
- / Towa Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Towa Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥3.1 K
2024-10-29
Market Capitalization
¥152.3 B
2024-10-29
Revenue
¥273.7 B
FY, 2026
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 | FY, 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 93.4B | 105.1B | 110.4B | 154.9B | 165.6B | 208.9B | 227.9B | 259.6B | 273.7B |
| Cost of goods sold | 42.2B | 48.4B | 51.5B | 79.0B | 84.5B | 116.7B | 128.7B | 144.8B | 151.8B |
| Gross profit | 51.2B | 56.7B | 58.9B | 75.9B | 81.1B | 92.1B | 99.3B | 114.8B | 121.9B |
| Gross profit margin, % | 54.8% | 54.0% | 53.4% | 49.0% | 49.0% | 44.1% | 43.6% | 44.2% | 44.6% |
| Operating expense total | 31.4B | 32.4B | 34.5B | 45.5B | 51.0B | 67.2B | 63.7B | 71.5B | 76.0B |
| Depreciation and amortization | 10.0B | 8.5B | 8.3B | 10.4B | 11.0B | 19.8B | 17.9B | 20.1B | 37.6B |
| EBITDA | 19.8B | 24.3B | 24.4B | 30.4B | 30.2B | 24.9B | 35.5B | 43.3B | 45.9B |
| EBITDA margin, % | 21.2% | 23.1% | 22.1% | 19.6% | 18.2% | 11.9% | 15.6% | 16.7% | 16.8% |
| EBIT | 9.7B | 16.2B | 16.1B | 19.9B | 18.5B | 6.7B | 18.7B | 24.9B | 9.2B |
| EBIT margin, % | 10.4% | 15.4% | 14.6% | 12.8% | 11.2% | 3.2% | 8.2% | 9.6% | 3.4% |
| Interest income | 58.0M | 48.0M | 81.0M | 23.0M | 8.0M | 17.0M | 97.0M | 221.0M | 309.0M |
| Interest expense | 158.0M | 146.0M | 131.0M | 190.0M | 230.0M | 635.0M | 947.0M | 1.6B | 2.3B |
| Pre tax profit | 9.8B | 18.9B | 20.7B | 18.7B | 22.2B | 4.6B | 24.5B | 26.3B | 13.2B |
| Income tax expense | 3.3B | 5.4B | 6.2B | 4.8B | 6.3B | 2.4B | 8.3B | 7.3B | 7.9B |
| Net Income | 6.5B | 13.5B | 14.5B | 14.0B | 15.9B | 2.2B | 16.2B | 19.0B | 5.2B |